Sprint Bioscience (Sweden) Profile

SEK 1.75  13.36%

Sprint Bioscience Summary

Sprint Bioscience AB (SPRINT) is traded on Stockholm Stock Exchange in Sweden. It is located in H?lsov?gen , th floorHuddinge, and employs 11 people. The company currently falls under 'Small-Cap' category with current market capitalization of 123.85 M. Sprint Bioscience AB operates under Healthcare sector and is part of Pharmaceuticals And Biosciences industry. This company has 7.57 M outstanding shares. SPRINT BIOSC has accumulated about 1.91 M in cash with (19.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.27.
Check Sprint Bioscience Probability Of Bankruptcy

Sprint Bioscience AB Risk Profiles

Key Fundamentals

Sprint Bioscience Against Markets

Current Ratings

Sprint Bioscience 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 49% 
Equity ratings for Sprint Bioscience AB are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Sprint Bioscience AB develops pharmaceutical solutions in the areas of cancer and metabolism. more
NameSprint Bioscience AB
CEOAnders AbergView All
Macroaxis Advice
Healthcare, Pharmaceuticals And Biosciences
InstrumentSweden Stock View All
Business AddressH?lsov?gen , th floorHuddinge,
ExchangeStockholm Stock Exchange
IndustryPharmaceuticals And Biosciences
Contact Number46 84 11 44 55
CurrencySEK - Swedish Kronor

Diversify with Sprint Bioscience AB

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Sprint Bioscience AB to your portfolio


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


Sprint Bioscience Corporate Directors
Jessica Martinsson Director Medicinal Chemistry, Director
Karin Meyer Director
AnneMarie Wenthzel Director of Sales and Marketing